Preferred Label : drug therapy, combination;

MeSH definition : Therapy with two or more separate preparations given for a combined effect.;

MeSH synonym : therapy, combination drug; combination chemotherapy; Drug Polytherapy; Drug Polytherapies; Polytherapies, Drug; therapies, combination drug; Polytherapy, Drug; chemotherapy, combination; chemotherapies, combination; combination chemotherapies; combination drug therapy; combination drug therapies; drug therapies, combination;

MeSH hyponym : polychemotherapy; Polychemotherapies;

MeSH annotation : IM when general; NIM when with specific drugs; differentiate from DRUG COMBINATIONS which is single preparation of multiple drugs; note entry term POLYCHEMOTHERAPY: do not confuse with POLYPHARMACY which is available for the use of multiple drugs administered to the same patient;

Details


Main resources

You can consult :

Therapy with two or more separate preparations given for a combined effect.

https://pepite-depot.univ-lille.fr/LIBRE/Th_Medecine/2022/2022ULILM250.pdf
2022
France
dissertations, academic
drug therapy, combination
antipsychotic agents
drugs, generic
review literature as topic
generic drug, nos
cholinergic antagonists
prescription, nos
anticholinergic agents
Literature

---
https://www.sfndt.org/sites/www.sfndt.org/files/medias/documents/Recommandations%20SFPT%20Interactions%20Paxlovid.pdf
2022
France
practice guideline
Paxlovid
drug therapy, combination
combined modality therapy
health planning guidelines
drug combinations
drug, nos
Treatments
Treatments

---
https://sfpt-fr.org/recospaxlovid
2022
France
guideline
drug, nos
Treatments
health planning guidelines
combined modality therapy
Paxlovid
Treatments
drug combinations
drug therapy, combination

---
https://www.cochrane.org/fr/CD012775/SYMPT_quelles-sont-les-meilleures-associations-de-medicaments-dans-la-prevention-des-nausees-et-des
2021
United Kingdom
review of literature
french abstract
chemotherapy
disease
neoplasms
Chemotherapy
Cancer
drug, nos
neoplasm, malignant
cancer
antiemetics
Adult
drug combinations
nausea and vomiting
adulthood
protective agents
chemotherapy, nos
adult
drug therapy, combination
Adult

---
https://www.cochrane.org/fr/CD010316/HTN_debut-du-traitement-de-lhypertension-avec-un-medicament-par-rapport-une-combinaison-de-deux
2020
France
United Kingdom
review of literature
french abstract
hypertensive disease, nos
drug, nos
pharmaceutical preparations
due to
research report
drug therapy
drug therapy, combination
albumin/globulin ratio
combined
hypertension
drug therapy

---
https://dumas.ccsd.cnrs.fr/dumas-02431850
2019
France
dissertations, academic
Mental health
anti-anxiety agents
patient acceptance of health care
drug therapy, combination
suicidal ideation
Suicide ideation
drug utilization
Mental health
mental health associations
health care
hypnotherapy
students
drug, nos
hypnotics
population
student, nos
hypnotics and sedatives
delivery of health care

---
https://www.revmed.ch/RMS/2017/RMS-N-565/Association-des-analogues-du-GLP-1-et-des-inhibiteurs-du-SGLT2-de-nouvelles-perspectives
2018
false
false
false
Switzerland
French
journal article
administration, oral
hypoglycemic agents
diabetes mellitus, type 2
switzerland
treatment outcome
body weight
cardiovascular diseases
drug therapy, combination
GLP-1 Mimetics
glucagon-like peptide 1
Glucagon-like peptide-1 (GLP-1) analogues
SGLT2 Inhibitor
Sodium-Glucose transporter 2
dulaglutide
Liraglutide
empagliflozin
dapagliflozin
Canagliflozin
blood glucose
arterial pressure
genetic pleiotropy
Sodium-glucose co-transporter 2 (SGLT2) inhibitors
Sodium-Glucose Transporter 2 Inhibitors
dapagliflozin
dapagliflozin
peptides
venoms
immunoglobulin fc fragments
recombinant fusion proteins
glucagon-like peptides
glucagon-like peptides
benzhydryl compounds
glucosides
Exenatide

---
http://www.cri-net.com/ckfinder/userfiles/files/fiches-pratiques/JAKi-juillet2018/JAK_14_Association_Med_VDEF_1218.pdf
2018
France
guideline
drug therapy, combination
disease management
arthritis, rheumatoid
Rheumatoid arthritis
temperance
severe
drug combinations
drug, nos
Polyarthritis

---
http://www.planetesante.ch/Magazine/Medicaments-examens-et-traitements/Traitements-medicamenteux/La-polypharmacie-une-nouvelle-epidemie
2018
false
false
false
France
French
popular works
epidemics
disease outbreaks
epidemics
drug therapy, combination
polypharmacy
Deprescriptions

---
http://www.cochrane.org/fr/CD010585/les-combinaisons-de-medicaments-pour-le-traitement-de-la-fibromyalgie-chez-ladulte
2018
false
false
false
false
France
United Kingdom
French
review of literature
drug therapy, combination
fibromyalgia
adult
Evidence-Based medicine
pain
treatment outcome
randomized controlled trials as topic

---
http://www.academie-medecine.fr/wp-content/uploads/2017/03/17.2.28-BOUVENOT-communiqué-site.pdf
2017
false
false
false
France
French
practice guideline
drug prescriptions
drug combinations
drug therapy, combination
treatment outcome
risk assessment
adult

---
https://www.revmed.ch/RMS/2016/RMS-N-520/Double-antiagregation-plaquettaire-pour-le-traitement-et-la-prevention-secondaire-de-la-maladie-coronarienne-Indications-modalites-et-durees-de-traitement
2017
false
false
false
Switzerland
French
journal article
secondary prevention
platelet aggregation inhibitors
coronary disease
coronary disease
Duration of treatment (qualifier value)
hemorrhage
platelet aggregation inhibitors
review of literature
drug therapy, combination
aspirin
administration, oral
treatment outcome
Prasugrel Hydrochloride
ischemia
purinergic P2Y receptor antagonists
purinergic P2Y receptor antagonists
purinergic P2Y12 receptor antagonists
purinergic P2Y12 receptor antagonists
percutaneous coronary intervention
acute coronary syndrome
practice guidelines as topic
ticlopidine
ticlopidine
adenosine
adenosine
Clopidogrel
Ticagrelor

---
https://www.has-sante.fr/portail/jcms/c_2666630/fr/contribution-des-associations-de-patients-et-d-usagers-aux-evaluations-de-medicaments-et-dispositifs-medicaux
2017
false
false
false
France
French
scientific and technical information
medical
medical devices
drug therapy, combination
drug combinations
drug, nos
drug evaluation
device, nos
equipment and supplies
has patient
societies, medical
patients

---
http://www.has-sante.fr/portail/jcms/c_2666630/en/contribution-des-associations-de-patients-et-d-usagers-aux-evaluations-de-medicaments-et-dispositifs-medicaux
http://www.has-sante.fr/portail/jcms/c_2681820/en/guide-pour-les-associations-de-patients-et-d-usagers-contribution-aux-evaluations-des-produits-de-sante
http://www.has-sante.fr/portail/jcms/c_2720917/en/methode-d-elaboration-par-la-has-contribution-des-associations-de-patients-et-d-usagers-aux-evaluations-de-medicaments-et-dispositifs-medicaux
2016
false
false
false
France
French
handbooks
drug therapy, combination
drug combinations
patients
societies, medical
drug evaluation
device, nos
medical devices
equipment and supplies
has patient
medical
drug, nos

---
https://www.revmed.ch/RMS/2016/RMS-N-521/Insuline-et-antidiabetiques-oraux-comment-les-associer-dans-la-pratique-ambulatoire
2016
false
false
false
Switzerland
French
journal article
hypoglycemic agents
administration, oral
injections, subcutaneous
insulin
drug therapy, combination
ambulatory care
diabetes mellitus, type 2
drugs used in diabetes
Glycated Hemoglobin
insulin
oral antidiabetics

---
http://hdl.handle.net/20.500.11794/26638
2016
false
true
false
Canada
French
dissertations, academic
diabetes non-insulin dependent
drug therapy, combination
hypoglycemic agents
diabetes mellitus, type 2
drug, nos
continuity of patient care

---
https://www.minerva-ebp.be/FR/Analysis/450
2016
false
true
false
Belgium
French
french abstract
scientific and technical information
drug therapy, combination
treatment outcome
glucosamine
osteoarthritis, knee
chondroitin

---
http://www.cochrane.org/fr/CD008532
http://www.cochrane.org/fr/CD008532/la-prise-de-tiotropium-en-plus-dinhalateurs-combines-est-elle-preferable-celle-de-tiotropium-ou-des
2016
false
false
false
France
United Kingdom
pulmonary disease, chronic obstructive
comparative effectiveness research
drug therapy, combination
Tiotropium Bromide
Evidence-Based medicine
quality of life
bronchodilator agents
glucocorticoids
adrenergic beta-2 receptor agonists
meta-analysis
french abstract
administration, inhalation

---
https://www.minerva-ebp.be/fr/analyses-en-ligne/237
2014
false
true
false
minerva-ebm.be
Belgium
French
french abstract
scientific and technical information
drug therapy, combination
aged
fibrinolytic agents

---
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2014/37895a-fra.php
2014
Canada
English
French
drug therapy, combination
antihypertensive agents
aliskiren
renin
drug interactions
angiotensin-converting enzyme inhibitors
angiotensin receptor antagonists
hypotension
hyperkalemia
kidney diseases
diabetes mellitus
kidney diseases
stroke
drug therapy, combination
syncope
pharmacovigilance note
patient education handout
amides
fumarates
Contraindications, Procedure

---
https://medias.vie-publique.fr/data_storage_s3/rapport/pdf/084000049.pdf
technical report
insurance, pharmaceutical services
appointments and schedules
patient escort service
financial support
drug therapy, combination

---
http://www.cochrane.org/fr/CD008989
2013
false
United Kingdom
France
French
Tiotropium Bromide
review of literature
pulmonary disease, chronic obstructive
treatment outcome
drug therapy, combination
adrenergic beta-2 receptor agonists
bronchodilator agents
french abstract

---
http://www.cochrane.org/fr/CD008943
2012
United Kingdom
France
French
meta-analysis
analgesics
neuralgia
treatment outcome
drug therapy, combination
adult
french abstract

---
https://medicalforum.ch/fr/detail/doi/fms.2011.07686/
2011
false
true
false
Switzerland
drug therapy, combination
drug therapy, combination
patient compliance
drug therapy, combination
drug therapy, combination
Contraindications, Procedure
journal article
polypharmacy

---
https://primary-hospital-care.ch/fr/article/doi/phc-f.2011.08913/
2011
false
true
false
Switzerland
drug therapy, combination
drug therapy, combination
drug therapy, combination
aged
adult
medication errors
drug interactions
journal article
polypharmacy

---
https://www.cochrane.org/fr/CD005332/DEPRESSN_medicaments-psychotherapie-ou-combinaison-des-deux-dans-le-traitement-de-la-dysmorphophobie
2009
France
United Kingdom
review of literature
french abstract
body dysmorphic disorders
body dysmorphic disorder
drug therapy
Dysmorphophobia
drug therapy, combination
drug, nos
psychotherapy
psychotherapy, nos
combined
drug therapy

---
http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2008:328:0042:0048:FR:PDF
2008
legislation
drug utilization
drug therapy, combination
plant preparations
drug combinations

---
http://revmed.ch/RMS/2005/RMS-35/30674
2005
Switzerland
French
osteoporosis
diphosphonates
treatment outcome
fractures, bone
bone density conservation agents
estrogens
drug therapy, combination
bone resorption
bisphosphonates
drug information
journal article
comparative study

---
https://ansm.sante.fr/uploads/2021/03/12/9379d489550abd7847f842ae671500fe.pdf
2005
false
France
English
French
antibiotic therapy
ceftizoxime
ceftizoxime
cefoxitin
cephalothin
cephaloridine
cephapirin
cefazolin
cefamandole
piperacillin
cefoperazone
cefotaxime
cefotetan
cefsulodin
ceftazidime
cephalosporins
ceftriaxone
moxalactam
colistin
bacteriology
colistin
polymyxin B
chlortetracycline
doxycycline
methacycline
minocycline
oxytetracycline
tetracycline
ethambutol
fosfomycin
teicoplanin
vancomycin
isoniazid
clindamycin
lincomycin
azithromycin
clarithromycin
erythromycin
erythromycin
sulfisoxazole
josamycin
leucomycins
roxithromycin
spiramycin
aztreonam
mupirocin
mupirocin
nitroimidazoles
metronidazole
nitrofurantoin
oxazolidinones
chloramphenicol
thiamphenicol
pyrazinamide
quinolones
nalidixic acid
oxolinic acid
pipemidic acid
fluoroquinolones
ciprofloxacin
enoxacin
ofloxacin
quinolones
aza compounds
quinolines
norfloxacin
pefloxacin
rifampin
sulfonamides
virginiamycin
virginiamycin
pristinamycin
trimethoprim
drug therapy, combination
penicillanic acid
cefixime
cephalosporin resistance
cefotiam
cefotiam
drug resistance, microbial
bacteria
fusidic acid
amikacin
prevalence
aminoglycosides
netilmicin
dibekacin
framycetin
kanamycin
neomycin
gentamicins
sisomicin
spectinomycin
streptomycin
europe
tobramycin
france
drug hypersensitivity
penicillins
penicillins
amoxicillin
ampicillin
clavulanic acid
administration, oral
injections
pivampicillin
probenecid
ampicillin
anti-bacterial agents
sulbactam
methicillin resistance
amdinocillin pivoxil
penicillin G
penicillin G benzathine
cloxacillin
dicloxacillin
floxacillin
oxacillin
penicillin V
mezlocillin
bacterial infections
penicillanic acid
ticarcillin
lactams
imipenem
thienamycins
cephalosporins
cefaclor
cephalexin
cefatrizine
cefadroxil
cephradine
cefuroxime
cefuroxime
directory
practice guideline

---
https://iris.who.int/discover?query=Polychimiotherapie%20contre%20la%20lepre%20:%20developpement%20et%20mise%20en%20oeuvre%20depuis%2025%20ans
2004
Switzerland
French
drug therapy, combination
leprosy
scientific and technical information

---
http://www.fmoq.org/Lists/FMOQDocumentLibrary/fr/Le%20M%C3%A9decin%20du%20Qu%C3%A9bec/Archives/2000%20-%202009/093-096PHBARETTE0703.pdf
2003
false
true
false
Canada
journal article
drug therapy, combination
prolonged qt interval

---
Nous contacter.
14/06/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.